Serum carcino‐embryonic antigen (CEA) is a relatively non‐specific antigen used in the clinical diagnosis of gastrointestinal cancer.14 The elevated level of CEA is found in some patients with poor HCC prognosis.15 Therefore, this marker may be useful for classification of prognosis. The gene discussed is CEACAM5; the disease is hepatocellular carcinoma.